Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer (Q63833223)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer |
clinical trial |
Statements
Phase I Trial of Nelfinavir and Bortezomib in Advanced Hematologic Malignancies (English)
0 references
July 2010
0 references
July 2012
0 references
18
0 references
18 year
0 references